Molecular mechanisms of fibrinolysis (original) (raw)

Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis

Hideto Sano

Current Drug Targets, 2019

View PDFchevron_right

Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces

Eduardo Angles-cano

Chemistry and Physics of Lipids, 1994

View PDFchevron_right

4 Pathophysiology of fibrinolysis

Marie-Christine Alessi

Baillière's Clinical Haematology, 1995

View PDFchevron_right

Fibrinolysis, inflammation, and regulation of the plasminogen activating system

Robert Medcalf

Journal of Thrombosis and Haemostasis, 2007

View PDFchevron_right

Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications

Patrick D Gaffney

Journal of Clinical Pathology, 1980

View PDFchevron_right

Location of plasminogen-binding sites in human fibrin(ogen)

László Patthy

Biochemistry, 1983

View PDFchevron_right

Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen

Patrick Grailhe

European Journal of Biochemistry, 1994

View PDFchevron_right

Blood fibrinolysis ; proactivators and activators in human plasma

Cornelis Kluft

1978

View PDFchevron_right

8 Fibrinolysis and thrombosis

Norma Tartas

Baillière's Clinical Haematology, 1994

View PDFchevron_right

Decreased plasmin resistance by clots of a homophenotypic Aα R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release)

dennis galanakis

Blood Coagulation & Fibrinolysis, 2010

View PDFchevron_right

Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis

Jeffrey Weitz

Journal of Clinical Investigation, 1991

View PDFchevron_right

Impaired fibrinolysis in coronary artery disease

Donald Feinstein

American Heart Journal, 1988

View PDFchevron_right

A Study of the Protection of Plasmin from Antiplasmin Inhibition within an Intact Fibrin Clot during the Course of Clot Lysis

tutu titi

Journal of Biological Chemistry, 2004

View PDFchevron_right

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

Helen Philippou

Diabetologia, 2006

View PDFchevron_right

Fibrinolytic cross-talk: a new mechanism for plasmin formation

Eduardo Angles-cano

…, 2010

View PDFchevron_right

Selection of animal model in fibrinolysis , a challenge

Juan Tentoni

2017

View PDFchevron_right

Fibrinolysis is amplified by converting α2‐antiplasmin from a plasmin inhibitor to a substrate

Inna Gladysheva

Journal of Thrombosis and Haemostasis, 2007

View PDFchevron_right

Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition

Bo Norrman

European Journal of Biochemistry, 1985

View PDFchevron_right

Clot penetration and retention by plasminogen activators promote fibrinolysis

Vladimir Muzykantov

Biochemical Pharmacology, 2013

View PDFchevron_right

Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation

Leonid Medved

Biochemistry, 1992

View PDFchevron_right

Molecular assembly of plasminogen and tissue‐type plasminogen activator on an evolving fibrin surface

Eduardo Angles-cano

European Journal …, 1993

View PDFchevron_right

Fibrin Clot Formation and Lysis: Basic Mechanisms

Jørgen Gram

Seminars in Thrombosis and Hemostasis, 2000

View PDFchevron_right

The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of α2-antiplasmin

Eduardo Angles-cano

Biochemical Journal, 1990

View PDFchevron_right

Plasma macromolecular protein complex: interaction with fibrin and fibrinolysis

Andrzej Krolewski

Thrombosis research, 1995

View PDFchevron_right

The role of 152Val of the fibrinogen Aα-chain in the fibrin-induced rate enhancement of the plasminogen activation by t-PA

Wim Schielen

Fibrinolysis, 1993

View PDFchevron_right

Comparative Fibrinolysis

Juan Tentoni

Fibrinolysis and Thrombolysis, 2014

View PDFchevron_right

Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained

Victor Gurewich

Journal of Clinical Investigation, 1988

View PDFchevron_right

Fibrinolysis is amplified by converting ? 2 -antiplasmin from a plasmin inhibitor to a substrate

Irina Sazonova

Journal of Thrombosis and Haemostasis, 2007

View PDFchevron_right

ENHANCEMENT OF THE STREPTOKINASE-INDUCED ACTIVATION OF HUMAN PLASMINOGEN BY HUMAN FIBRINOGEN AND HUMAN FIBRINOGEN FRAGMENT D 1

Bakshy A Chibber

Annals of the New York Academy of Sciences, 1983

View PDFchevron_right

Type 1 Plasminogen Activator Inhibitor Binds to Fibrin via Vitronectin

Jeffrey Weitz

Journal of Biological Chemistry, 2000

View PDFchevron_right